FINANCIALS

SEEL Seelos Therapeutics Inc 1017491

Income Statement
Revenue	seel-20240630x10q	376,000
Net Income	seel-20240630x10q	1,710,000
Profit Margin		454.79%

Balance Sheet
Current Assets	2,334,000
Assets	2,381,000
Current Liabilities	30,514,000
Liabilities	30,514,000
Equity	-28,133,000
Shares Out	6,975,000

Cash Flow Statement
Operating Cash Flow	-5,614,000

Market Analysis
Market Cap	1,492,196
BVPS	3.35
PB	0.01
EPS	9.76
PE	0.02
PS	0.99

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view SEEL documents filed with the SEC.

SEEL Filings Clear

View A List of Tickers